Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment.

Autor: Li GL; Department of Pharmaceutical Technology, Leiden Amsterdam Centre for Drug Research, University of Leiden, P.O. Box 9502, 2300 RA, Leiden, The Netherlands., de Vries JJ, van Steeg TJ, van den Bussche H, Maas HJ, Reeuwijk HJ, Danhof M, Bouwstra JA, van Laar T

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2005 Jan 03; Vol. 101 (1-3), pp. 199-208.

Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.

Autor: Van Der Heyden SA; Laboratory for Experimental Oncology, University of Leuven, B-3000 Leuven, Belgium., Highley MS, De Bruijn EA, Tjaden UR, Reeuwijk HJ, Van Slooten H, Van Oosterom AT, Maes RA

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 1999 Apr; Vol. 47 (4), pp. 351-6.

Simultaneous determination of furosemide and amiloride in plasma using high-performance liquid chromatography with fluorescence detection.

Autor: Reeuwijk HJ; Center for Bio-Pharmaceutical Sciences, University of Leiden, Netherlands., Tjaden UR, van der Greef J

Publikováno v: Journal of chromatography [J Chromatogr] 1992 Mar 27; Vol. 575 (2), pp. 269-74.

Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.

Autor: de Bruijn EA, van Oosterom AT, Tjaden UR, Reeuwijk HJ, Pinedo HM

Publikováno v: Cancer research [Cancer Res] 1985 Nov; Vol. 45 (11 Pt 2), pp. 5931-5.

Reversed-phase ion-pair analysis of 5-fluorouracil in pig bile, liver homogenate, plasma and urine after administration by isolated liver perfusion.

Autor: Bierman JA; Division of Analytical Chemistry, Leiden University, The Netherlands., Lingeman H, Reeuwijk HJ, de Bruijn EA, Tjaden UR, van der Greef J

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 1989; Vol. 7 (5), pp. 611-7.